Skip to content

Łukasz P. Szałach

4 papers in the library · 79 citations · publishing 2020-2025

Papers

Sort Most recent Most cited

The Effect of Ketamine on the Immune System in Patients with Treatment-Resistant Depression

International Journal of Molecular Sciences August 1, 2025 Łukasz P. Szałach, Klaudia Ciesielska-Figlon, A. Daca et al. 7 citations

Treatment-resistant depression (TRD) is associated with immune dysregulation. Ketamine, a rapid-acting antidepressant, may exert effects via immunomodulation. The aim was to examine ketamine’s impact on immune markers in TRD, including T-cell subsets, cytokines, and in vitro T-cell responses. Eighteen TRD inpatients received 0.5 mg/kg iv ketamine. Blood was sampled at baseline, 4 h, and 24 h to...

Gut Microbiota in Depression: A Focus on Ketamine

Frontiers in Behavioral Neuroscience June 23, 2021 Alina Wilkowska, Łukasz P. Szałach, Wiesław Jerzy Cubała 32 citations

According to the WHO, major depressive disorder is the leading cause of disability worldwide, and it is a major contributor to the overall global burden of disease. The pathophysiology of this common and chronic disease is still not completely understood. The gut microbiome is an increasingly recognized environmental factor that can have a role in depression, acting through the...

Ketamine in Bipolar Disorder: A Review

Neuropsychiatric Disease and Treatment November 1, 2020 Alina Wilkowska, Łukasz P. Szałach, Wiesław Jerzy Cubała 31 citations

Abstract: Bipolar disorder (BD) is a psychiatric illness associated with high morbidity, mortality and suicide rate. It has neuroprogressive course and a high rate of treatment resistance. Hence, there is an unquestionable need for new BD treatment strategies. Ketamine appears to have rapid antidepressive and antisuicidal effects. Since most of the available studies concern unipolar depression,...

Affective Switch Associated With Oral, Low Dose Ketamine Treatment in a Patient With Treatment Resistant Bipolar I Depression. Case Report and Literature Review

Frontiers in Psychiatry June 3, 2020 Alina Wilkowska, Łukasz P. Szałach, Jakub Słupski et al. 9 citations

There is a growing evidence for the rapid and robust antidepressive effect of ketamine in unipolar and bipolar treatment resistant depression although evidence for the risk of affective switch is still limited. This case presents bipolar I disorder patient with treatment resistant depressive episode experiencing a switch to manic episode with mixed features shortly after receiving eight...